Susquehanna International Group, LLP Regenxbio Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

A detailed history of Susquehanna International Group, LLP transactions in Regenxbio Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 16,629 shares of RGNX stock, worth $181,256. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,629

Previous 20,028 16.97%

Holding current value

$181,256

Previous $359,000 2.51%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$12.17 - $24.61 $41,365 - $83,649	-3,399 Reduced 16.97%	16,629 $350,000
Q4 2023 Feb 14, 2024	SELL	$12.89 - $20.82 $85,241 - $137,682	-6,613 Reduced 24.82%	20,028 $359,000
Q3 2023 Nov 14, 2023	BUY	$16.46 - $19.99 $159,316 - $193,483	9,679 Added 57.06%	26,641 $438,000
Q2 2023 Aug 11, 2023	SELL	$17.23 - $21.71 $641,627 - $808,458	-37,239 Reduced 68.71%	16,962 $339,000
Q1 2023 May 16, 2023	BUY	$18.08 - $24.55 $706,023 - $958,677	39,050 Added 257.74%	54,201 $1.02 Million

Q4 2022 Feb 14, 2023	SELL	$20.4 - $24.73 $709,144 - $859,664	-34,762 Reduced 69.65%	15,151 $343,000
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $1.11 Million - $1.75 Million	49,913 New	49,913 $1.32 Million
Q1 2022 May 16, 2022	SELL	$24.62 - $34.31 $273,897 - $381,698	-11,125 Reduced 26.17%	31,382 $1.04 Million
Q4 2021 Feb 14, 2022	SELL	$30.19 - $40.28 $2,747 - $3,665	-91 Reduced 0.21%	42,507 $1.39 Million
Q3 2021 Nov 15, 2021	BUY	$29.09 - $45.68 $544,739 - $855,403	18,726 Added 78.44%	42,598 $1.79 Million
Q2 2021 Aug 11, 2021	BUY	$32.46 - $40.48 $189,176 - $235,917	5,828 Added 32.3%	23,872 $927,000
Q1 2021 May 17, 2021	BUY	$33.61 - $49.95 $284,239 - $422,427	8,457 Added 88.21%	18,044 $615,000
Q4 2020 Feb 16, 2021	SELL	$26.52 - $49.35 $345,873 - $643,622	-13,042 Reduced 57.63%	9,587 $435,000
Q3 2020 Nov 16, 2020	BUY	$27.01 - $40.26 $8,130 - $12,118	301 Added 1.35%	22,629 $623,000
Q2 2020 Aug 14, 2020	SELL	$27.75 - $43.44 $388,555 - $608,246	-14,002 Reduced 38.54%	22,328 $822,000
Q1 2020 May 15, 2020	SELL	$21.5 - $54.2 $588,326 - $1.48 Million	-27,364 Reduced 42.96%	36,330 $1.18 Million
Q4 2019 Feb 14, 2020	SELL	$34.54 - $44.87 $1.7 Million - $2.21 Million	-49,245 Reduced 43.6%	63,694 $2.61 Million
Q3 2019 Nov 14, 2019	BUY	$31.84 - $50.88 $1.11 Million - $1.77 Million	34,747 Added 44.44%	112,939 $4.02 Million
Q2 2019 Aug 16, 2019	BUY	$42.0 - $59.29 $619,164 - $874,053	14,742 Added 23.23%	78,192 $4.02 Million
Q2 2019 Aug 14, 2019	BUY	$42.0 - $59.29 $1.85 Million - $2.61 Million	43,974 Added 225.79%	63,450 $3.26 Million
Q1 2019 May 15, 2019	SELL	$40.82 - $62.45 $87,763 - $134,267	-2,150 Reduced 9.94%	19,476 $1.12 Million
Q4 2018 Feb 14, 2019	BUY	$39.11 - $75.15 $28,980 - $55,686	741 Added 3.55%	21,626 $907,000
Q1 2018 May 15, 2018	SELL	$24.05 - $37.5 $1.48 Million - $2.3 Million	-61,437 Reduced 74.63%	20,885 $623,000
Q4 2017 Feb 14, 2018	BUY	$26.0 - $34.6 $2.14 Million - $2.85 Million	82,322	82,322 $2.74 Million

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

42.1M

Call Options Held

80.6K

Put Options Held

55.2K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $471M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Regenxbio Inc. Transaction History